검색결과 : 6건
| No. | Article |
|---|---|
| 1 |
SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801 Wahl A, Gralinski LE, Johnson CE, Yao WB, Kovarova M, Dinnon KH, Liu HW, Madden VJ, Krzystek HM, De C, White KK, Gully K, Schafer A, Zaman T, Leist SR, Grant PO, Bluemling GR, Kolykhalov AA, Natchus MG, Askin FB, Painter G, Browne EP, Jones CD, Pickles RJ, Baric RS, Garcia JV Nature, 591(7850), 451, 2021 |
| 2 |
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, Himansu S, Schafer A, Ziwawo CT, DiPiazza AT, Dinnon KH, Elbashir SM, Shaw CA, Woods A, Fritch EJ, Martinez DR, Bock KW, Minai M, Nagata BM, Hutchinson GB, Wu K, Henry C, Bahl K, Garcia-Dominguez D, Ma LZ, Renzi I, Kong WP, Schmidt SD, Wang LS, Zhang Y, Phung E, Chang LA, Loomis RJ, Altaras NE, Narayanan E, Metkar M, Presnyak V, Liu C, Louder MK, Shi W, Leung K, Yang ES, West A, Gully KL, West A, Gully KL, Wang NS, Wrapp D, Doria-Rose NA, Stewart-Jones G, Bennett H, Alvarado GS, Nason MC, Ruckwardt TJ, McLellan JS, Denison MR, Chappell JD, Moore IN, Morabito KM, Mascola JR, Baric RS, Carfi A, Graham BS Nature, 586(7830), 567, 2020 |
| 3 |
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures Dinnon KH, Leist SR, Schafer A, Edwards CE, Martinez DR, Montgomery SA, West A, Yount BL, Hou YXJ, Adams LE, Gully KL, Brown AJ, Huang E, Bryant MD, Choong IC, Glenn JS, Gralinski LE, Sheahan TP, Baric RS Nature, 586(7830), 560, 2020 |
| 4 |
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, Gillespie RA, Himansu S, Schafer A, Ziwawo CT, DiPiazza AT, Dinnon KH, Elbashir SM, Shaw CA, Woods A, Fritch EJ, Martinez DR, Bock KW, Minai M, Nagata BM, Hutchinson GB, Wu K, Henry C, Bahl K, Garcia-Dominguez D, Ma LZ, Renzi I, Kong WP, Schmidt SD, Wang LS, Zhang Y, Phung E, Chang LA, Loomis RJ, Altaras NE, Narayanan E, Metkar M, Presnyak V, Liu C, Louder MK, Shi W, Leung K, Yang ES, West A, Gully KL, West A, Gully KL, Wang NS, Wrapp D, Doria-Rose NA, Stewart-Jones G, Bennett H, Alvarado GS, Nason MC, Ruckwardt TJ, McLellan JS, Denison MR, Chappell JD, Moore IN, Morabito KM, Mascola JR, Baric RS, Carfi A, Graham BS Nature, 586(7830), 567, 2020 |
| 5 |
A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures Dinnon KH, Leist SR, Schafer A, Edwards CE, Martinez DR, Montgomery SA, West A, Yount BL, Hou YXJ, Adams LE, Gully KL, Brown AJ, Huang E, Bryant MD, Choong IC, Glenn JS, Gralinski LE, Sheahan TP, Baric RS Nature, 586(7830), 560, 2020 |
| 6 |
SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo Hou YXJ, Chiba S, Halfmann P, Ehre C, Kuroda M, Dinnon KH, Leist SR, Schafer A, Nakajima N, Takahashi K, Lee RE, Mascenik TM, Graham R, Edwards CE, Tse LV, Okuda K, Markmann AJ, Bartelt L, de Silva A, Margolis DM, Boucher RC, Randell SH, Suzuki T, Gralinski LE, Kawaoka Y, Baric RS Science, 370(6523), 1464, 2020 |